HER2-Altered Non-Small Cell Lung Cancer — Rapid Case Review
About this episode
This episode features a rapid case review of HER2-altered non-small cell lung cancer with insights from Dr Mark Jeng and Dr Joshua K Sabari.
Featuring an interview with Dr Mark Jeng and Dr Joshua K Sabari, including the following topics: Case: A woman in her late 90s with recurrent HER2-mutant metastatic non-small cell lung cancer (NSCLC) receives third-line zongertinib (0:00) Case: A woman in her early 60s with multiregimen-recurrent HER2-mutant metastatic NSCLC experiences a response to zongertinib (8:07) Case: A man in his mid 80s experiences metastatic recurrence after resection of PD-L1-positive, HER2-mutant metastatic NSCLC (17:50) CME information and select publications
More episodes of Lung Cancer Update
- Nonmetastatic Non-Small Cell Lung Cancer — An Interview with Dr Jamie E Chaft
- For Oncology Nurses: Strategies to Safely and Effectively Implement Antibody-Drug Conjugates — Proceedings from the 2026 Annual ONS Congress
- Targeted Therapies for Non-Small Cell Lung Cancer — Fifth Annual National General Medical Oncology Summit
- EGFR-Mutated Non-Small Cell Lung Cancer — Fifth Annual National General Medical Oncology Summit
- First-Line and Maintenance Therapy for Patients with Extensive-Stage Small Cell Lung Cancer — An Interview with Prof Martin Reck
Explore listener stats, chart rankings, contacts and more on the Lung Cancer Update podcast page.